Non-US bivalent oral polio vaccine (types 1 and 3)
Semantic Scholar uses AI to extract papers important to this topic.
ABSTRACT Bivalent rLP2086 (Trumenba), a vaccine for prevention of Neisseria meningitidis serogroup B (NmB) disease, was licensed… Expand Background: In February 2015, two unlinked culture-confirmed cases of Neisseria meningitidis serogroup B (MenB) disease occurred… Expand ABSTRACT Objective: To outline the reasoning behind use of bivalent rLP2086 in a Rhode Island college meningococcal B disease… Expand Background Neisseria meningitidis serogroup B (MnB) is a leading cause of invasive meningococcal disease in adolescents and young… Expand Key points Concomitant administration of bivalent rLP2086 (Trumenba [Pfizer, Inc] and diphtheria, tetanus, and acellular… Expand Background: This study in healthy adolescents (11 to <18 years) evaluated coadministration of quadrivalent human papillomavirus… Expand More than 2 million AIDS-related deaths occurred globally in 2008, and more than 33 million people are living with HIV/AIDS… Expand Abstract: We recently reported that the pathogenesis of pemphigus vulgaris (PV), an autoimmune blistering skin disorder, is… Expand BACKGROUND
Effective vaccination against HPV 16 and HPV 18 to prevent cervical cancer will require a high level of sustained… Expand OBJECTIVE
To evaluate the efficacy of a modified-live virus (MLV) combination vaccine containing type 1 and type 2 bovine viral… Expand